[HTML] mdpi.com

[HTML][HTML] Improving osteosarcoma treatment: comparative oncology in action

L Tarone, K Mareschi, E Tirtei, D Giacobino… - Life, 2022 - mdpi.com
Osteosarcoma (OSA) is the most common pediatric malignant bone tumor. Although surgery
together with neoadjuvant/adjuvant chemotherapy has improved survival for localized OSA …
被引用次数：4 相关文章

Improving Osteosarcoma Treatment: Comparative Oncology in Action

L Tarone, K Mareschi, E Tirtei… - Life (Basel …, 2022 - pubmed.ncbi.nlm.nih.gov
Osteosarcoma (OSA) is the most common pediatric malignant bone tumor. Although surgery
together with neoadjuvant/adjuvant chemotherapy has improved survival for localized OSA …
[PDF] semanticscholar.org

[PDF][PDF] Improving Osteosarcoma Treatment: Comparative Oncology in Action

L Tarone, K Mareschi, E Tirtei, D Giacobino… - Life, 2022 - pdfs.semanticscholar.org
Osteosarcoma (OSA) is the most common pediatric malignant bone tumor. Although surgery
together with neoadjuvant/adjuvant chemotherapy has improved survival for localized OSA …

Improving Osteosarcoma Treatment: Comparative Oncology in Action

L Tarone, K Mareschi, E Tirtei, D Giacobino… - LIFE, 2022 - iris.unito.it
Osteosarcoma (OSA) is the most common pediatric malignant bone tumor. Although surgery
together with neoadjuvant/adjuvant chemotherapy has improved survival for localized OSA …

Improving Osteosarcoma Treatment: Comparative Oncology in Action

L Tarone, K Mareschi, E Tirtei, D Giacobino… - Life, 2022 - search.proquest.com
Osteosarcoma (OSA) is the most common pediatric malignant bone tumor. Although surgery
together with neoadjuvant/adjuvant chemotherapy has improved survival for localized OSA …

Improving Osteosarcoma Treatment: Comparative Oncology in Action.

L Tarone, K Mareschi, E Tirtei, D Giacobino… - Life (2075 …, 2022 - search.ebscohost.com
Osteosarcoma (OSA) is the most common pediatric malignant bone tumor. Although surgery
together with neoadjuvant/adjuvant chemotherapy has improved survival for localized OSA …

Improving Osteosarcoma Treatment: Comparative Oncology in Action.

L Tarone, K Mareschi, E Tirtei, D Giacobino… - Life (Basel …, 2022 - europepmc.org
Osteosarcoma (OSA) is the most common pediatric malignant bone tumor. Although surgery
together with neoadjuvant/adjuvant chemotherapy has improved survival for localized OSA …
[HTML] nih.gov

[HTML][HTML] Improving Osteosarcoma Treatment: Comparative Oncology in Action

L Tarone, K Mareschi, E Tirtei, D Giacobino… - Life, 2022 - ncbi.nlm.nih.gov
Osteosarcoma (OSA) is the most common pediatric malignant bone tumor. Although surgery
together with neoadjuvant/adjuvant chemotherapy has improved survival for localized OSA …

Improving Osteosarcoma Treatment: Comparative Oncology in Action

L Tarone, K Mareschi, E Tirtei, D Giacobino… - Life, 2022 - ui.adsabs.harvard.edu
Osteosarcoma (OSA) is the most common pediatric malignant bone tumor. Although surgery
together with neoadjuvant/adjuvant chemotherapy has improved survival for localized OSA …
[PDF] unito.it

[PDF][PDF] Improving Osteosarcoma Treatment: Comparative Oncology in Action

L Tarone, K Mareschi, E Tirtei, D Giacobino… - Life, 2022 - iris.unito.it
Osteosarcoma (OSA) is the most common pediatric malignant bone tumor. Although surgery
together with neoadjuvant/adjuvant chemotherapy has improved survival for localized OSA …